Please login to the form below

Not currently logged in

Valeant continues on acquisition trail

Canadian pharmaceutical company Valeant has reportedly made a takeover bid for Medicis Pharmaceutical

Valeant Pharmaceuticals has made a takeover bid for Medicis Pharmaceutical, according to The Wall Street Journal.

An acquisition of Medicis, which makes dermatological and aesthetic pharmaceutical products, would fit with Valeant's stated goal of becoming a leader in the sector. 

According to reports, Arizona-based Medicis has been left vulnerable to a takeover approach as its shares have underperformed the broader market following the unusual death of its chief executive Jonah Shacknai's girlfriend, who was found bound, nude and hanged from a balcony at his mansion near San Diego in July.

Valeant has been on the acquisition trail since it failed in May to acquire US rival Cephalon for $5.7bn. In February it bought the privately held firm PharmaSwiss for €350m in a move to strengthen its European presence. It acquired AC Santos in May, and in July 2011 it bought Sanofi's Dermik dermatology unit for $425m.

At the end of July Valeant was rumoured to be considering making a bid for Swedish-based pharmaceutical company Meda.

9th August 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...